Abstract
MicroRNAs are short non-coding RNA species that serve as post-transcriptional regulators of mRNA expression and they have a pivotal role in all cellular functions. Recently, there has been a great interest in deciphering the role of miRNAs in human diseases with a growing possibility of exploiting miRNAs in therapy as well. A miRNA can either be the primary cause of a disease, or be directly or indirectly involved in developing a pathological phenotype. Furthermore, miRNAs have been implicated in complex genetic diseases, while many researchers attempt to build miRNA expression maps characterizing specific diseases. Such findings assist in the better understanding of miRNA functions, dissect the biological background of a disease, as well as become a springboard for the development or improvement of prognostic, diagnostic and therapeutic tools. This chapter aims in providing a concise description of how miRNAs are responsible in the developing pathology of human disease, as well as provide an overview of the workflow followed in miRNA studies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281–297
Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136(2):215–233
Friedman RC, Farh KK, Burge CB, Bartel DP (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19(1):92–105
Dweep H, Gretz N, Sticht C (2014) miRWalk database for miRNA-target interactions. Methods Mol Biol 1182:289–305
Kumar A, Wong AK, Tizard ML, Moore RJ, Lefevre C (2012) miRNA_Targets: a database for miRNA target predictions in coding and non-coding regions of mRNAs. Genomics 100(6):352–356
Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120(1):15–20
Enright AJ, John B, Gaul U, Tuschl T, Sander C, Marks DS (2003) MicroRNA targets in Drosophila. Genome Biol 5(1):R1
Wang X (2008) miRDB: a microRNA target prediction and functional annotation database with a wiki interface. RNA 14(6):1012–1017
Miranda KC, Huynh T, Tay Y, Ang YS, Tam WL, Thomson AM et al (2006) A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell 126(6):1203–1217
Chi SW, Zang JB, Mele A, Darnell RB (2009) Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature 460(7254):479–486
Zhang B, Pan X, Cobb GP, Anderson TA (2007) microRNAs as oncogenes and tumor suppressors. Dev Biol 302(1):1–12
Vinther J, Hedegaard MM, Gardner PP, Andersen JS, Arctander P (2006) Identification of miRNA targets with stable isotope labeling by amino acids in cell culture. Nucleic Acids Res 34(16):e107
Kim YK, Yeo J, Kim B, Ha M, Kim VN (2012) Short structured RNAs with low GC content are selectively lost during extraction from a small number of cells. Mol Cell 46(6):893–895
Zeringer E, Li M, Barta T, Schageman J, Pedersen KW, Neurauter A et al (2013) Methods for the extraction and RNA profiling of exosomes. World J Methodol 3(1):11–18
Schageman J, Zeringer E, Li M, Barta T, Lea K, Gu J et al (2013) The complete exosome workflow solution: from isolation to characterization of RNA cargo. Biomed Res Int 2013:253957
Rio DC (2014) Northern blots for small RNAs and microRNAs. Cold Spring Harb Protoc 2014(7):793–797
Raymond CK, Roberts BS, Garrett-Engele P, Lim LP, Johnson JM (2005) Simple, quantitative primer-extension PCR assay for direct monitoring of microRNAs and short-interfering RNAs. RNA 11(11):1737–1744
Ro S, Park C, Jin J, Sanders KM, Yan W (2006) A PCR-based method for detection and quantification of small RNAs. Biochem Biophys Res Commun 351(3):756–763
Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT et al (2005) Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33(20):e179
Li Y, Kowdley KV (2012) Method for microRNA isolation from clinical serum samples. Anal Biochem 431(1):69–75
McAlexander MA, Phillips MJ, Witwer KW (2013) Comparison of methods for miRNA extraction from plasma and quantitative recovery of RNA from cerebrospinal fluid. Front Genet 4:83
Turchinovich A, Weiz L, Langheinz A, Burwinkel B (2011) Characterization of extracellular circulating microRNA. Nucleic Acids Res 39(16):7223–7233
Nuovo GJ (2008) In situ detection of precursor and mature microRNAs in paraffin embedded, formalin fixed tissues and cell preparations. Methods 44(1):39–46
Wu M, Piccini M, Koh CY, Lam KS, Singh AK (2013) Single cell microRNA analysis using microfluidic flow cytometry. PLoS One 8(1):e55044
Porichis F, Hart MG, Griesbeck M, Everett HL, Hassan M, Baxter AE et al (2014) High-throughput detection of miRNAs and gene-specific mRNA at the single-cell level by flow cytometry. Nat Commun 5:5641
de Planell-Saguer M, Rodicio MC (2011) Analytical aspects of microRNA in diagnostics: a review. Anal Chim Acta 699(2):134–152
Yin JQ, Zhao RC, Morris KV (2008) Profiling microRNA expression with microarrays. Trends Biotechnol 26(2):70–76
Hafner M, Landgraf P, Ludwig J, Rice A, Ojo T, Lin C et al (2008) Identification of microRNAs and other small regulatory RNAs using cDNA library sequencing. Methods 44(1):3–12
Zollner H, Hahn SA, Maghnouj A (2014) Quantitative RT-PCR specific for precursor and mature miRNAs. Methods Mol Biol 1095:121–134
Hafner M, Landthaler M, Burger L, Khorshid M, Hausser J, Berninger P et al (2010) Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 141(1):129–141
Helwak A, Kudla G, Dudnakova T, Tollervey D (2013) Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. Cell 153(3):654–665
Gong J, Tong Y, Zhang HM, Wang K, Hu T, Shan G et al (2012) Genome-wide identification of SNPs in microRNA genes and the SNP effects on microRNA target binding and biogenesis. Hum Mutat 33(1):254–263
Mencia A, Modamio-Hoybjor S, Redshaw N, Morin M, Mayo-Merino F, Olavarrieta L et al (2009) Mutations in the seed region of human miR-96 are responsible for nonsyndromic progressive hearing loss. Nat Genet 41(5):609–613
Solda G, Robusto M, Primignani P, Castorina P, Benzoni E, Cesarani A et al (2012) A novel mutation within the MIR96 gene causes non-syndromic inherited hearing loss in an Italian family by altering pre-miRNA processing. Hum Mol Genet 21(3):577–585
Dorn GW 2nd, Matkovich SJ, Eschenbacher WH, Zhang Y (2012) A human 3′ miR-499 mutation alters cardiac mRNA targeting and function. Circ Res 110(7):958–967
Ryan DG, Oliveira-Fernandes M, Lavker RM (2006) MicroRNAs of the mammalian eye display distinct and overlapping tissue specificity. Mol Vis 12:1175–1184
Hughes AE, Bradley DT, Campbell M, Lechner J, Dash DP, Simpson DA et al (2011) Mutation altering the miR-184 seed region causes familial keratoconus with cataract. Am J Hum Genet 89(5):628–633
Iliff BW, Riazuddin SA, Gottsch JD (2012) A single-base substitution in the seed region of miR-184 causes EDICT syndrome. Invest Ophthalmol Vis Sci 53(1):348–353
Bykhovskaya Y, Caiado Canedo AL, Wright KW, Rabinowitz YS (2013) C.57 C > T Mutation in MIR 184 is Responsible for Congenital Cataracts and Corneal Abnormalities in a Five-generation Family from Galicia, Spain. Ophthalmic Genet DOI:10.3109/13816810.2013.848908
Lechner J, Bae HA, Guduric-Fuchs J, Rice A, Govindarajan G, Siddiqui S et al (2013) Mutational analysis of MIR184 in sporadic keratoconus and myopia. Invest Ophthalmol Vis Sci 54(8):5266–5272
Georges M, Clop A, Marcq F, Takeda H, Pirottin D, Hiard S et al (2006) Polymorphic microRNA-target interactions: a novel source of phenotypic variation. Cold Spring Harb Symp Quant Biol 71:343–350
Hariharan M, Scaria V, Brahmachari SK (2009) dbSMR: a novel resource of genome-wide SNPs affecting microRNA mediated regulation. BMC Bioinformatics 10:108
Bao L, Zhou M, Wu L, Lu L, Goldowitz D, Williams RW et al (2007) PolymiRTS Database: linking polymorphisms in microRNA target sites with complex traits. Nucleic Acids Res 35(Database issue):D51–D54
Liu C, Zhang F, Li T, Lu M, Wang L, Yue W et al (2012) MirSNP, a database of polymorphisms altering miRNA target sites, identifies miRNA-related SNPs in GWAS SNPs and eQTLs. BMC Genomics 13:661
Abelson JF, Kwan KY, O'Roak BJ, Baek DY, Stillman AA, Morgan TM et al (2005) Sequence variants in SLITRK1 are associated with Tourette’s syndrome. Science 310(5746):317–320
Beetz C, Schule R, Deconinck T, Tran-Viet KN, Zhu H, Kremer BP et al (2008) REEP1 mutation spectrum and genotype/phenotype correlation in hereditary spastic paraplegia type 31. Brain 131(Pt 4):1078–1086
Zuchner S, Wang G, Tran-Viet KN, Nance MA, Gaskell PC, Vance JM et al (2006) Mutations in the novel mitochondrial protein REEP1 cause hereditary spastic paraplegia type 31. Am J Hum Genet 79(2):365–369
Gale DP, de Jorge EG, Cook HT, Martinez-Barricarte R, Hadjisavvas A, McLean AG et al (2010) Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis. Lancet 376(9743):794–801
Athanasiou Y, Voskarides K, Gale DP, Damianou L, Patsias C, Zavros M et al (2011) Familial C3 glomerulopathy associated with CFHR5 mutations: clinical characteristics of 91 patients in 16 pedigrees. Clin J Am Soc Nephrol 6(6):1436–1446
Papagregoriou G, Erguler K, Dweep H, Voskarides K, Koupepidou P, Athanasiou Y et al (2012) A miR-1207-5p binding site polymorphism abolishes regulation of HBEGF and is associated with disease severity in CFHR5 nephropathy. PLoS One 7(2):e31021
Cezar-de-Mello PF, Toledo-Pinto TG, Marques CS, Arnez LE, Cardoso CC, Guerreiro LT et al (2014) Pre-miR-146a (rs2910164 G>C) single nucleotide polymorphism is genetically and functionally associated with leprosy. PLoS Negl Trop Dis 8(9):e3099
Chae YS, Kim JG, Lee SJ, Kang BW, Lee YJ, Park JY et al (2013) A miR-146a polymorphism (rs2910164) predicts risk of and survival from colorectal cancer. Anticancer Res 33(8):3233–3239
Chen G, Umelo IA, Lv S, Teugels E, Fostier K, Kronenberger P et al (2013) miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cells. PLoS One 8(3):e60317
Zhu H, Cai P, Zhu D, Xu C, Li H, Tang J et al (2014) A common polymorphism in pre-miR-146a underlies Hirschsprung disease risk in Han Chinese. Exp Mol Pathol 97(3):511–514
Wang N, Li Y, Zhou RM, Wang GY, Wang CM, Chen ZF et al (2014) Hsa-miR-196a2 functional SNP is associated with the risk of ESCC in individuals under 60 years old. Biomarkers 19(1):43–48
Buraczynska M, Zukowski P, Wacinski P, Ksiazek K, Zaluska W (2014) Polymorphism in microRNA-196a2 contributes to the risk of cardiovascular disease in type 2 diabetes patients. J Diabetes Complications 28(5):617–620
Haixia D, Hairong D, Weixian C, Min Y, Qiang W, Hang X (2012) Lack of association of polymorphism in miRNA-196a2 with Parkinson’s disease risk in a Chinese population. Neurosci Lett 514(2):194–197
Ryan BM, Robles AI, Harris CC (2010) Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer 10(6):389–402
Gilam A, Edry L, Mamluk-Morag E, Bar-Ilan D, Avivi C, Golan D et al (2013) Involvement of IGF-1R regulation by miR-515-5p modifies breast cancer risk among BRCA1 carriers. Breast Cancer Res Treat 138(3):753–760
Nicoloso MS, Sun H, Spizzo R, Kim H, Wickramasinghe P, Shimizu M et al (2010) Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility. Cancer Res 70(7):2789–2798
Cheng M, Yang L, Yang R, Yang X, Deng J, Yu B et al (2013) A microRNA-135a/b binding polymorphism in CD133 confers decreased risk and favorable prognosis of lung cancer in Chinese by reducing CD133 expression. Carcinogenesis 34(10):2292–2299
Lytle JR, Yario TA, Steitz JA (2007) Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5′ UTR as in the 3′ UTR. Proc Natl Acad Sci U S A 104(23):9667–9672
Tsai NP, Lin YL, Wei LN (2009) MicroRNA mir-346 targets the 5′-untranslated region of receptor-interacting protein 140 (RIP140) mRNA and up-regulates its protein expression. Biochem J 424(3):411–418
Orom UA, Nielsen FC, Lund AH (2008) MicroRNA-10a binds the 5′ UTR of ribosomal protein mRNAs and enhances their translation. Mol Cell 30(4):460–471
Forman JJ, Coller HA (2010) The code within the code: microRNAs target coding regions. Cell Cycle 9(8):1533–1541
Akhtar N, Makki MS, Haqqi TM (2015) MicroRNA-602 and microRNA-608 regulate sonic hedgehog expression via target sites in the coding region in human chondrocytes. Arthritis Rheumatol 67(2):423–434
Mandke P, Wyatt N, Fraser J, Bates B, Berberich SJ, Markey MP (2012) MicroRNA-34a modulates MDM4 expression via a target site in the open reading frame. PLoS One 7(8):e42034
Zhou H, Rigoutsos I (2014) MiR-103a-3p targets the 5′ UTR of GPRC5A in pancreatic cells. RNA 20(9):1431–1439
Kim NH, Cha YH, Kang SE, Lee Y, Lee I, Cha SY et al (2013) p53 regulates nuclear GSK-3 levels through miR-34-mediated Axin2 suppression in colorectal cancer cells. Cell Cycle 12(10):1578–1587
Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P (2005) Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 309(5740):1577–1581
Mishra PJ, Banerjee D, Bertino JR (2008) MiRSNPs or MiR-polymorphisms, new players in microRNA mediated regulation of the cell: Introducing microRNA pharmacogenomics. Cell Cycle 7(7):853–858
Mishra PJ, Humeniuk R, Longo-Sorbello GS, Banerjee D, Bertino JR (2007) A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance. Proc Natl Acad Sci U S A 104(33):13513–13518
Dai E, Lv Y, Meng F, Yu X, Zhang Y, Wang S et al (2014) CREAM: a database for chemotherapy resistance-associated miRSNP. Cell Death Dis 5:e1272
Ward A, Shukla K, Balwierz A, Soons Z, Konig R, Sahin O et al (2014) MicroRNA-519a is a novel oncomir conferring tamoxifen resistance by targeting a network of tumour-suppressor genes in ER+ breast cancer. J Pathol 233(4):368–379
Esquela-Kerscher A, Slack FJ (2006) Oncomirs – microRNAs with a role in cancer. Nat Rev Cancer 6(4):259–269
Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S et al (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 101(9):2999–3004
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646–674
Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E et al (2002) Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 99(24):15524–15529
Aqeilan RI, Calin GA, Croce CM (2010) miR-15a and miR-16-1 in cancer: discovery, function and future perspectives. Cell Death Differ 17(2):215–220
Cortez MA, Bueso-Ramos C, Ferdin J, Lopez-Berestein G, Sood AK, Calin GA (2011) MicroRNAs in body fluids--the mix of hormones and biomarkers. Nat Rev Clin Oncol 8(8):467–477
Hermeking H (2010) The miR-34 family in cancer and apoptosis. Cell Death Differ 17(2):193–199
Wang LQ, Kwong YL, Wong KF, Kho CS, Jin DY, Tse E et al (2014) Epigenetic inactivation of mir-34b/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia. J Transl Med 12:52
Wang Z, Chen Z, Gao Y, Li N, Li B, Tan F et al (2011) DNA hypermethylation of microRNA-34b/c has prognostic value for stage non-small cell lung cancer. Cancer Biol Ther 11(5):490–496
Javeri A, Ghaffarpour M, Taha MF, Houshmand M (2013) Downregulation of miR-34a in breast tumors is not associated with either p53 mutations or promoter hypermethylation while it correlates with metastasis. Med Oncol 30(1):413
Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL et al (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105(30):10513–10518
Taylor DD, Gercel-Taylor C (2008) MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 110(1):13–21
Cheng H, Zhang L, Cogdell DE, Zheng H, Schetter AJ, Nykter M et al (2011) Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis. PLoS One 6(3):e17745
Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N et al (2008) MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 299(4):425–436
Iorio MV, Casalini P, Tagliabue E, Menard S, Croce CM (2008) MicroRNA profiling as a tool to understand prognosis, therapy response and resistance in breast cancer. Eur J Cancer 44(18):2753–2759
Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M et al (2006) Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9(3):189–198
Si ML, Zhu S, Wu H, Lu Z, Wu F, Mo YY (2007) miR-21-mediated tumor growth. Oncogene 26(19):2799–2803
Markou A, Liang Y, Lianidou E (2011) Prognostic, therapeutic and diagnostic potential of microRNAs in non-small cell lung cancer. Clin Chem Lab Med 49(10):1591–1603
Chen H, Lan HY, Roukos DH, Cho WC (2014) Application of microRNAs in diabetes mellitus. J Endocrinol 222(1):R1–R10
Lynn FC, Skewes-Cox P, Kosaka Y, McManus MT, Harfe BD, German MS (2007) MicroRNA expression is required for pancreatic islet cell genesis in the mouse. Diabetes 56(12):2938–2945
Kalis M, Bolmeson C, Esguerra JL, Gupta S, Edlund A, Tormo-Badia N et al (2011) Beta-cell specific deletion of Dicer1 leads to defective insulin secretion and diabetes mellitus. PLoS One 6(12):e29166
Joglekar MV, Parekh VS, Mehta S, Bhonde RR, Hardikar AA (2007) MicroRNA profiling of developing and regenerating pancreas reveal post-transcriptional regulation of neurogenin3. Dev Biol 311(2):603–612
Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma X, Macdonald PE et al (2004) A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432(7014):226–230
Poy MN, Hausser J, Trajkovski M, Braun M, Collins S, Rorsman P et al (2009) miR-375 maintains normal pancreatic alpha- and beta-cell mass. Proc Natl Acad Sci U S A 106(14):5813–5818
El Ouaamari A, Baroukh N, Martens GA, Lebrun P, Pipeleers D, van Obberghen E (2008) miR-375 targets 3′-phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic beta-cells. Diabetes 57(10):2708–2717
Latreille M, Hausser J, Stutzer I, Zhang Q, Hastoy B, Gargani S et al (2014) MicroRNA-7a regulates pancreatic beta cell function. J Clin Invest 124(6):2722–2735
Sun LL, Jiang BG, Li WT, Zou JJ, Shi YQ, Liu ZM (2011) MicroRNA-15a positively regulates insulin synthesis by inhibiting uncoupling protein-2 expression. Diabetes Res Clin Pract 91(1):94–100
Fred RG, Bang-Berthelsen CH, Mandrup-Poulsen T, Grunnet LG, Welsh N (2010) High glucose suppresses human islet insulin biosynthesis by inducing miR-133a leading to decreased polypyrimidine tract binding protein-expression. PLoS One 5(5):e10843
Lovis P, Gattesco S, Regazzi R (2008) Regulation of the expression of components of the exocytotic machinery of insulin-secreting cells by microRNAs. Biol Chem 389(3):305–312
Plaisance V, Abderrahmani A, Perret-Menoud V, Jacquemin P, Lemaigre F, Regazzi R (2006) MicroRNA-9 controls the expression of Granuphilin/Slp4 and the secretory response of insulin-producing cells. J Biol Chem 281(37):26932–26942
Lovis P, Roggli E, Laybutt DR, Gattesco S, Yang JY, Widmann C et al (2008) Alterations in microRNA expression contribute to fatty acid-induced pancreatic beta-cell dysfunction. Diabetes 57(10):2728–2736
Esau C, Kang X, Peralta E, Hanson E, Marcusson EG, Ravichandran LV et al (2004) MicroRNA-143 regulates adipocyte differentiation. J Biol Chem 279(50):52361–52365
Chen L, Hou J, Ye L, Chen Y, Cui J, Tian W et al (2014) MicroRNA-143 regulates adipogenesis by modulating the MAP2K5-ERK5 signaling. Sci Rep 4:3819
Ling HY, Ou HS, Feng SD, Zhang XY, Tuo QH, Chen LX et al (2009) CHANGES IN microRNA (miR) profile and effects of miR-320 in insulin-resistant 3T3-L1 adipocytes. Clin Exp Pharmacol Physiol 36(9):e32–e39
Xie H, Lim B, Lodish HF (2009) MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity. Diabetes 58(5):1050–1057
Erener S, Mojibian M, Fox JK, Denroche HC, Kieffer TJ (2013) Circulating miR-375 as a biomarker of beta-cell death and diabetes in mice. Endocrinology 154(2):603–608
Zampetaki A, Kiechl S, Drozdov I, Willeit P, Mayr U, Prokopi M et al (2010) Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res 107(6):810–817
Zhong X, Chung AC, Chen HY, Dong Y, Meng XM, Li R et al (2013) miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes. Diabetologia 56(3):663–674
Wang X, Sundquist J, Zoller B, Memon AA, Palmer K, Sundquist K et al (2014) Determination of 14 circulating microRNAs in Swedes and Iraqis with and without diabetes mellitus type 2. PLoS One 9(1):e86792
Krichevsky AM, Sonntag KC, Isacson O, Kosik KS (2006) Specific microRNAs modulate embryonic stem cell-derived neurogenesis. Stem Cells 24(4):857–864
Kawase-Koga Y, Low R, Otaegi G, Pollock A, Deng H, Eisenhaber F et al (2010) RNAase-III enzyme Dicer maintains signaling pathways for differentiation and survival in mouse cortical neural stem cells. J Cell Sci 123(Pt 4):586–594
Cho HJ, Liu G, Jin SM, Parisiadou L, Xie C, Yu J et al (2013) MicroRNA-205 regulates the expression of Parkinson’s disease-related leucine-rich repeat kinase 2 protein. Hum Mol Genet 22(3):608–620
Esteves AR, Swerdlow RH, Cardoso SM (2014) LRRK2, a puzzling protein: insights into Parkinson’s disease pathogenesis. Exp Neurol 261:206–216
Gehrke S, Imai Y, Sokol N, Lu B (2010) Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression. Nature 466(7306):637–641
Kim J, Inoue K, Ishii J, Vanti WB, Voronov SV, Murchison E et al (2007) A microRNA feedback circuit in midbrain dopamine neurons. Science 317(5842):1220–1224
Doxakis E (2010) Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153. J Biol Chem 285(17):12726–12734
Patel N, Hoang D, Miller N, Ansaloni S, Huang Q, Rogers JT et al (2008) MicroRNAs can regulate human APP levels. Mol Neurodegener 3:10
Dickson JR, Kruse C, Montagna DR, Finsen B, Wolfe MS (2013) Alternative polyadenylation and miR-34 family members regulate tau expression. J Neurochem 127(6):739–749
Hu YK, Wang X, Li L, Du YH, Ye HT, Li CY (2013) MicroRNA-98 induces an Alzheimer’s disease-like disturbance by targeting insulin-like growth factor 1. Neurosci Bull 29(6):745–751
Smith P, Al Hashimi A, Girard J, Delay C, Hebert SS (2011) In vivo regulation of amyloid precursor protein neuronal splicing by microRNAs. J Neurochem 116(2):240–247
Schonrock N, Ke YD, Humphreys D, Staufenbiel M, Ittner LM, Preiss T et al (2010) Neuronal microRNA deregulation in response to Alzheimer’s disease amyloid-beta. PLoS One 5(6):e11070
Yan R, Vassar R (2014) Targeting the beta secretase BACE1 for Alzheimer’s disease therapy. Lancet Neurol 13(3):319–329
Hebert SS, Horre K, Nicolai L, Papadopoulou AS, Mandemakers W, Silahtaroglu AN et al (2008) Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer’s disease correlates with increased BACE1/beta-secretase expression. Proc Natl Acad Sci U S A 105(17):6415–6420
Wang WX, Rajeev BW, Stromberg AJ, Ren N, Tang G, Huang Q et al (2008) The expression of microRNA miR-107 decreases early in Alzheimer’s disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J Neurosci 28(5):1213–1223
Wang X, Liu P, Zhu H, Xu Y, Ma C, Dai X et al (2009) miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer’s disease, inhibits bcl2 translation. Brain Res Bull 80(4–5):268–273
Alexandrov PN, Dua P, Lukiw WJ (2014) Up-regulation of miRNA-146a in progressive, age-related inflammatory neurodegenerative disorders of the human CNS. Front Neurol 5:181
Saba R, Gushue S, Huzarewich RL, Manguiat K, Medina S, Robertson C et al (2012) MicroRNA 146a (miR-146a) is over-expressed during prion disease and modulates the innate immune response and the microglial activation state. PLoS One 7(2):e30832
Williams AE, Perry MM, Moschos SA, Larner-Svensson HM, Lindsay MA (2008) Role of miRNA-146a in the regulation of the innate immune response and cancer. Biochem Soc Trans 36(Pt 6):1211–1215
Tan L, Yu JT, Liu QY, Tan MS, Zhang W, Hu N et al (2014) Circulating miR-125b as a biomarker of Alzheimer’s disease. J Neurol Sci 336(1–2):52–56
Liu CG, Wang JL, Li L, Wang PC (2014) MicroRNA-384 regulates both amyloid precursor protein and beta-secretase expression and is a potential biomarker for Alzheimer’s disease. Int J Mol Med 34(1):160–166
Zi Y, Yin Z, Xiao W, Liu X, Gao Z, Jiao L et al (2014) Circulating microRNA as potential source for neurodegenerative diseases biomarkers. Mol Neurobiol DOI:10.1007/s12035-014-8944-x
Ma X, Zhou J, Zhong Y, Jiang L, Mu P, Li Y et al (2014) Expression, regulation and function of microRNAs in multiple sclerosis. Int J Med Sci 11(8):810–818
Toivonen JM, Manzano R, Olivan S, Zaragoza P, Garcia-Redondo A, Osta R (2014) MicroRNA-206: a potential circulating biomarker candidate for amyotrophic lateral sclerosis. PLoS One 9(2):e89065
Bronze-da-Rocha E (2014) MicroRNAs expression profiles in cardiovascular diseases. Biomed Res Int 2014:985408
Thum T, Galuppo P, Wolf C, Fiedler J, Kneitz S, van Laake LW et al (2007) MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation 116(3):258–267
Chen JF, Murchison EP, Tang R, Callis TE, Tatsuguchi M, Deng Z et al (2008) Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure. Proc Natl Acad Sci U S A 105(6):2111–2116
Bostjancic E, Zidar N, Stajer D, Glavac D (2010) MicroRNAs miR-1, miR-133a, miR-133b and miR-208 are dysregulated in human myocardial infarction. Cardiology 115(3):163–169
Sayed D, Hong C, Chen IY, Lypowy J, Abdellatif M (2007) MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ Res 100(3):416–424
Montgomery RL, Hullinger TG, Semus HM, Dickinson BA, Seto AG, Lynch JM et al (2011) Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure. Circulation 124(14):1537–1547
Bonauer A, Carmona G, Iwasaki M, Mione M, Koyanagi M, Fischer A et al (2009) MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 324(5935):1710–1713
Weber M, Baker MB, Moore JP, Searles CD (2010) MiR-21 is induced in endothelial cells by shear stress and modulates apoptosis and eNOS activity. Biochem Biophys Res Commun 393(4):643–648
Nazari-Jahantigh M, Wei Y, Noels H, Akhtar S, Zhou Z, Koenen RR et al (2012) MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages. J Clin Invest 122(11):4190–4202
Wei Y, Nazari-Jahantigh M, Neth P, Weber C, Schober A (2013) MicroRNA-126, −145, and −155: a therapeutic triad in atherosclerosis? Arterioscler Thromb Vasc Biol 33(3):449–454
Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M et al (2005) Silencing of microRNAs in vivo with ‘antagomirs’. Nature 438(7068):685–689
Rayner KJ, Suarez Y, Davalos A, Parathath S, Fitzgerald ML, Tamehiro N et al (2010) MiR-33 contributes to the regulation of cholesterol homeostasis. Science 328(5985):1570–1573
Rotllan N, Ramirez CM, Aryal B, Esau CC, Fernandez-Hernando C (2013) Therapeutic silencing of microRNA-33 inhibits the progression of atherosclerosis in Ldlr−/− mice--brief report. Arterioscler Thromb Vasc Biol 33(8):1973–1977
van Rooij E, Sutherland LB, Thatcher JE, DiMaio JM, Naseem RH, Marshall WS et al (2008) Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci U S A 105(35):13027–13032
Soci UP, Fernandes T, Hashimoto NY, Mota GF, Amadeu MA, Rosa KT et al (2011) MicroRNAs 29 are involved in the improvement of ventricular compliance promoted by aerobic exercise training in rats. Physiol Genomics 43(11):665–673
Hullinger TG, Montgomery RL, Seto AG, Dickinson BA, Semus HM, Lynch JM et al (2012) Inhibition of miR-15 protects against cardiac ischemic injury. Circ Res 110(1):71–81
Li S, Zhu J, Zhang W, Chen Y, Zhang K, Popescu LM et al (2011) Signature microRNA expression profile of essential hypertension and its novel link to human cytomegalovirus infection. Circulation 124(2):175–184
Courboulin A, Paulin R, Giguere NJ, Saksouk N, Perreault T, Meloche J et al (2011) Role for miR-204 in human pulmonary arterial hypertension. J Exp Med 208(3):535–548
Yang S, Banerjee S, Freitas A, Cui H, Xie N, Abraham E et al (2012) miR-21 regulates chronic hypoxia-induced pulmonary vascular remodeling. Am J Physiol Lung Cell Mol Physiol 302(6):L521–L529
Bostjancic E, Glavac D (2014) miRNome in myocardial infarction: future directions and perspective. World J Cardiol 6(9):939–958
Corsten MF, Dennert R, Jochems S, Kuznetsova T, Devaux Y, Hofstra L et al (2010) Circulating microRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease. Circ Cardiovasc Genet 3(6):499–506
Kuwabara Y, Ono K, Horie T, Nishi H, Nagao K, Kinoshita M et al (2011) Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage. Circ Cardiovasc Genet 4(4):446–454
Long G, Wang F, Duan Q, Yang S, Chen F, Gong W et al (2012) Circulating miR-30a, miR-195 and let-7b associated with acute myocardial infarction. PLoS One 7(12):e50926
Harvey SJ, Jarad G, Cunningham J, Goldberg S, Schermer B, Harfe BD et al (2008) Podocyte-specific deletion of dicer alters cytoskeletal dynamics and causes glomerular disease. J Am Soc Nephrol 19(11):2150–2158
Shi S, Yu L, Chiu C, Sun Y, Chen J, Khitrov G et al (2008) Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis. J Am Soc Nephrol 19(11):2159–2169
Ho J, Ng KH, Rosen S, Dostal A, Gregory RI, Kreidberg JA (2008) Podocyte-specific loss of functional microRNAs leads to rapid glomerular and tubular injury. J Am Soc Nephrol 19(11):2069–2075
Zhdanova O, Srivastava S, Di L, Li Z, Tchelebi L, Dworkin S et al (2011) The inducible deletion of Drosha and microRNAs in mature podocytes results in a collapsing glomerulopathy. Kidney Int 80(7):719–730
Sun Y, Koo S, White N, Peralta E, Esau C, Dean NM et al (2004) Development of a micro-array to detect human and mouse microRNAs and characterization of expression in human organs. Nucleic Acids Res 32(22):e188
Tian Z, Greene AS, Pietrusz JL, Matus IR, Liang M (2008) MicroRNA-target pairs in the rat kidney identified by microRNA microarray, proteomic, and bioinformatic analysis. Genome Res 18(3):404–411
Dalla Vestra M, Arboit M, Bruseghin M, Fioretto P (2009) The kidney in type 2 diabetes: focus on renal structure. Endocrinol Nutr 56(Suppl 4):18–20
Kato M, Zhang J, Wang M, Lanting L, Yuan H, Rossi JJ et al (2007) MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci U S A 104(9):3432–3437
Wang Q, Wang Y, Minto AW, Wang J, Shi Q, Li X et al (2008) MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy. FASEB J 22(12):4126–4135
Zhang Z, Peng H, Chen J, Chen X, Han F, Xu X et al (2009) MicroRNA-21 protects from mesangial cell proliferation induced by diabetic nephropathy in db/db mice. FEBS Lett 583(12):2009–2014
Stitt-Cavanagh E, MacLeod L, Kennedy C (2009) The podocyte in diabetic kidney disease. ScientificWorldJournal 9:1127–1139
Wang G, Kwan BC, Lai FM, Choi PC, Chow KM, Li PK et al (2010) Intrarenal expression of miRNAs in patients with hypertensive nephrosclerosis. Am J Hypertens 23(1):78–84
Zhang W, Zhang C, Chen H, Li L, Tu Y, Liu C et al (2014) Evaluation of microRNAs miR-196a, miR-30a-5P, and miR-490 as biomarkers of disease activity among patients with FSGS. Clin J Am Soc Nephrol 9(9):1545–1552
Denby L, Ramdas V, McBride MW, Wang J, Robinson H, McClure J et al (2011) miR-21 and miR-214 are consistently modulated during renal injury in rodent models. Am J Pathol 179(2):661–672
Ichii O, Otsuka S, Sasaki N, Namiki Y, Hashimoto Y, Kon Y (2012) Altered expression of microRNA miR-146a correlates with the development of chronic renal inflammation. Kidney Int 81(3):280–292
Lu J, Kwan BC, Lai FM, Tam LS, Li EK, Chow KM et al (2012) Glomerular and tubulointerstitial miR-638, miR-198 and miR-146a expression in lupus nephritis. Nephrology (Carlton) 17(4):346–351
Wang G, Kwan BC, Lai FM, Choi PC, Chow KM, Li PK et al (2010) Intrarenal expression of microRNAs in patients with IgA nephropathy. Lab Invest 90(1):98–103
Sui W, Yang M, Li F, Chen H, Chen J, Ou M et al (2014) Serum microRNAs as new diagnostic biomarkers for pre- and post-kidney transplantation. Transplant Proc 46(10):3358–3362
Deltas C, Papagregoriou G (2010) Cystic diseases of the kidney: molecular biology and genetics. Arch Pathol Lab Med 134(4):569–582
Lee SO, Masyuk T, Splinter P, Banales JM, Masyuk A, Stroope A et al (2008) MicroRNA15a modulates expression of the cell-cycle regulator Cdc25A and affects hepatic cystogenesis in a rat model of polycystic kidney disease. J Clin Invest 118(11):3714–3724
Pandey P, Brors B, Srivastava PK, Bott A, Boehn SN, Groene HJ et al (2008) Microarray-based approach identifies microRNAs and their target functional patterns in polycystic kidney disease. BMC Genomics 9:624
Patel V, Williams D, Hajarnis S, Hunter R, Pontoglio M, Somlo S et al (2013) miR-17~92 miRNA cluster promotes kidney cyst growth in polycystic kidney disease. Proc Natl Acad Sci U S A 110(26):10765–10770
Agostini M, Knight RA (2014) miR-34: from bench to bedside. Oncotarget 5(4):872–881
Zhao X, Pan F, Holt CM, Lewis AL, Lu JR (2009) Controlled delivery of antisense oligonucleotides: a brief review of current strategies. Expert Opin Drug Deliv 6(7):673–686
Shimakami T, Yamane D, Welsch C, Hensley L, Jangra RK, Lemon SM (2012) Base pairing between hepatitis C virus RNA and microRNA 122 3′ of its seed sequence is essential for genome stabilization and production of infectious virus. J Virol 86(13):7372–7383
Lindow M, Kauppinen S (2012) Discovering the first microRNA-targeted drug. J Cell Biol 199(3):407–412
Elmen J, Lindow M, Schutz S, Lawrence M, Petri A, Obad S et al (2008) LNA-mediated microRNA silencing in non-human primates. Nature 452(7189):896–899
Lanford RE, Hildebrandt-Eriksen ES, Petri A, Persson R, Lindow M, Munk ME et al (2010) Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 327(5962):198–201
Janssen HL, Reesink HW, Lawitz EJ, Zeuzem S, Rodriguez-Torres M, Patel K et al (2013) Treatment of HCV infection by targeting microRNA. N Engl J Med 368(18):1685–1694
Liu C, Kelnar K, Liu B, Chen X, Calhoun-Davis T, Li H et al (2011) The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med 17(2):211–215
Craig VJ, Tzankov A, Flori M, Schmid CA, Bader AG, Muller A (2012) Systemic microRNA-34a delivery induces apoptosis and abrogates growth of diffuse large B-cell lymphoma in vivo. Leukemia 26(11):2421–2424
Wiggins JF, Ruffino L, Kelnar K, Omotola M, Patrawala L, Brown D et al (2010) Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34. Cancer Res 70(14):5923–5930
Bader AG (2012) miR-34 – a microRNA replacement therapy is headed to the clinic. Front Genet 3:120
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Papagregoriou, G. (2015). MicroRNAs in Disease. In: Felekkis, K., Voskarides, K. (eds) Genomic Elements in Health, Disease and Evolution. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-3070-8_2
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3070-8_2
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-3069-2
Online ISBN: 978-1-4939-3070-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)